Eden helps streamline that process by connecting you with experienced providers who can provide medical guidance and, when appropriate, coordinate prescriptions through state-licensed compounding pharmacies
Given the high prevalence of both diabetes and dementia in aging populations, this strategy may reduce long-term public health burdens, including healthcare costs, caregiver stress, and institutionalization needs. Szu-Yuan Wu, MD, MPH, PhD The researcher team also discovered that study participants taking GLP-1 agonists had a 25% lower risk of developing non-vascular dementias and a 12% lower chance of developing Alzheimers disease, compared to participants taking metformin
Matrix metalloproteinase-9 delays wound healing in a murine wound model

Exercise & Muscle Preservation Prioritize resistance training muscle mass raises resting metabolic rate Aim for 150+ minutes of moderate aerobic activity weekly Protein intake of 1.21.6g per kg of body weight supports muscle retention Even 30 min walks significantly blunt post-medication weight regain Nutrition Habits Prioritize high-volume, high-fiber foods to naturally manage hunger Reduce ultra-processed foods that bypass satiety signals Eat protein at every meal to support satiety without medication Time meals consistently irregular eating drives more hunger Behavioral Support Work with a registered dietitian during and after tapering Track weight weekly to catch early regain (5+ lbs) and respond quickly Address emotional eating patterns before stopping Set a clear plan with your provider before your last dose Medical Follow-up Schedule a follow-up 46 weeks after stopping to monitor weight and labs Discuss blood sugar monitoring if you had elevated glucose Reassess at 6 months if regain exceeds 10%, discuss restarting Don't wait until significant regain occurs to reach back out to your provider The Case for Staying on Treatment If you're considering stopping because of cost, side effects, or uncertainty about long-term use it's worth having a direct conversation with your provider before making that call

In preclinical models, BPC 157 has been shown to modulate a broad range of cellular and molecular pathways